Your browser doesn't support javascript.
loading
Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma.
Brown, Ross; Murray, Allan; Pope, Belinda; Sze, Daniel M; Gibson, John; Ho, P Joy; Hart, Derek; Joshua, Doug.
Affiliation
  • Brown R; Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia. rbrown@haem.rpa.cs.nsw.gov.au
Br J Haematol ; 125(6): 743-8, 2004 Jun.
Article in En | MEDLINE | ID: mdl-15180863
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Dendritic Cells / Immunotherapy, Active / Transforming Growth Factor beta / Interferon-gamma / Interleukin-12 / Multiple Myeloma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Br J Haematol Year: 2004 Document type: Article Affiliation country: Australia Country of publication: United kingdom
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Dendritic Cells / Immunotherapy, Active / Transforming Growth Factor beta / Interferon-gamma / Interleukin-12 / Multiple Myeloma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Br J Haematol Year: 2004 Document type: Article Affiliation country: Australia Country of publication: United kingdom